Ayala Pharmaceuticals Current Cash

Ayala Pharmaceuticals (AYLA) currently reports a current cash of $2.4M as of December 2022. That compares with $37M in the prior-year period — down 93.5% year over year. Use the charts on this page to explore Ayala Pharmaceuticals's current cash history and peer comparisons.

Ayala Pharmaceuticals's current cash decreased from $37M to $2.4M — a 93.5% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ayala Pharmaceuticals reported $2.4M in current cash as of December 2022. That compares with $37M in the prior-year period — down 93.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $2.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ayala Pharmaceuticals, and consider following AYLA for alerts when major investors trade the stock.

Ayala Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $2.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AYLA with unrelated industries.